Investment criteria

We invest in middle-market healthcare companies.

We invest within the biotechnology, healthcare services, healthcare technology, medical devices, and pharmaceutical sectors.

We actively seek companies with robust growth potential.

Our goal is to build market leaders.  We typically look to partner with companies that have superior management teams, clearly identified competitive advantages, significant barriers to entry, positive cash flow, and revenues between $10MM - $100MM.

We typically participate in control equity transactions.

We participate in control equity transactions and will make strategic minority investments on special occasions.  Continued involvement of management teams is an essential component of positive growth trajectory, and we develop transaction structures in which management retains an equity position.